The aim is non-invasive measuring of cardiovascular respiratory and autonomic nervous system dynamics. The systolic force, minute cardiac force, heart rate, variability of the heart rhythm and respiratory frequency are all measured.
Vascular diseases (stroke, myocardial infarction, peripheral vessel occlusion) are still increasing in western countries. To improve the early diagnosis and therapy of this generalised disease, combined analysis needs to be provided
To develop 'cancer microarray cgh kit' for ovarian and prostate cancer for molecular caryotyping from bac dna clones in order to reduce the cost of analysis of each single region and make the technology widely usable in research and medical institutions.
Delfia kits for 1st trimester preeclampsia (5-7% of pregnancies) tests will be developed with europium fluorometry & computerised robotic arms for accurate & fast testing. Verified clinically, and fda & ce registered, the kit will improve patient access & enhance sales for women's health.
To develop, at an industrial level, the first production and refining for plant lipases, and to identify different types of vegetal latex for use as raw material in the extraction of enzymes with commercial value.
To promote the development and production of modern diagnostic and therapeutic radionuclides and radioimmunopharmaceuticals in new member and associated eu countries.
To develop a polymer scaffold that induces chondrogenesis of bone marrow derived mesenchymal cells and enables the generation of hyaline cartilage when implanted in cartilage defects in combination with standard microfracture treatment.
Personalised medicine has been targeted as the most important future development in both medicine and drug development. The final product that synergistically combines the two companies' capabilities will be a software platform.
In a concerted effort, dnage, biobide and academia will set up a novel drug development tool. A new method for rapid identification of new therapeutics in the field of osteoporosis and other ageing related diseases will be developed.
New methods and techniques for modifying polymer foils to improve their bio-functions using extreme ultraviolet (euv) radiation from laser plasma light sources which will be developed during the project for biomedical technology.